Liver Diseases  >>  Intron A (interferon α-2b)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Intron A (interferon α-2b) / Merck (MSD), Biogen
NCT00140725: Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)

Completed
3
160
RoW
Lamivudine plus Polyethylene glyco-interferon alfa-2b, Lamivudine
GlaxoSmithKline
Chronic Hepatitis B
 
 
SCIN-C, NCT00624325: Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders

Completed
2/3
30
Europe
interferon alfa-2b, Intron A
Foundation for Liver Research
Chronic Hepatitis C
06/10
12/10

Download Options